Labshake search
Citations for Cellgenix :
1 - 18 of 18 citations for 6 Chloro N 5 ethoxy 1H pyrazol 3 yl 3 nitropyridin 2 amine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... thrombopoetin (TPO) and Flt-3 ligand (both from CellGenix, Freiburg, Germany). An overnight pre-treatment incubation was carried out after thaw at 37 °C ...
-
bioRxiv - Biochemistry 2024Quote: ... FMS-like Tyrosine Kinase 3 Ligand (Flt3L, 100 ng/ml) (CellGenix, 1415-050) and Thrombopoietin (TPO ...
-
bioRxiv - Genetics 2023Quote: ... and 100 ng ml-1 Preclinical FMS-like Tyrosine Kinase 3 Ligand (FLT3L) (CellGenix, cat# 1415-050). HSPCs were electroporated with 3xNLS-SpCas9:sgRNA or 3xNLS-HiFi- SpCas9:sgRNA RNP immediately ...
-
bioRxiv - Genetics 2021Quote: ... and 100 ng ml-1 recombinant human FMS-like Tyrosine Kinase 3 Ligand (Flt3-L) (CellGenix cat# 1415-050). HSPCs were electroporated with 3xNLS-SpCas9:sg1617 RNP or HiFi-3xNLS-SpCas9:sg1617 RNP 24 h after thawing ...
-
bioRxiv - Molecular Biology 2023Quote: At least 5×107-3×108 Cryopreserved CD34+ HSPCs were then thawed at 37 °C and cultured in supplemented cytokine rich SCGM media (CellGenix) containing recombinant cytokines at 100 ng/mL each Flt-3L ...
-
bioRxiv - Systems Biology 2020Quote: ... 1 000 U/mL IL-6 (CellGenix), 10 ng/mL TNF (Beromun ...
-
bioRxiv - Genomics 2020Quote: ... and 250IU/mL of recombinant human interleukin-2 (rhIL-2, CellGenix GmbH). Cells were activated with soluble human anti-CD3 (clone OKT3 ...
-
bioRxiv - Cell Biology 2023Quote: ... 2) GT culture conditions: GMP SCGM (CellGenix) supplemented with L-Glutamine (1% ...
-
bioRxiv - Immunology 2022Quote: ... containing 100 U/mL recombinant human IL-2 (rhIL-2, Novartis Oncology) and 0.5 ng/mL recombinant human IL-15 (rhIL-15, CellGenix). For CAR lentiviral transduction ...
-
bioRxiv - Immunology 2022Quote: ... CD3-negative PBMCs were then seeded in 6-well plates at a density of 1×106 cells/ml in GMP SCGM media (CellGenix) with 10% heat-inactivated FBS ...
-
bioRxiv - Cancer Biology 2022Quote: ... and IL-2 (100 U/ml) (Cellgenix Cat# 1020-050) for 2 days ...
-
bioRxiv - Immunology 2023Quote: ... and recombinant human IL-2 (rhIL2,50 U/mL; R&D Systems/CellGenix)) with or without 1% penicillin/streptomycin/l-glutamine (Invitrogen) ...
-
bioRxiv - Cancer Biology 2019Quote: ... DCs were collected and cocultured with autologous CD8+ T cells with the ratio between 1:4 to 1:10 in AIM-V medium with 5% autologous serum and 30 ng/ml IL-21 (Cellgenix, Germany). Two days later ...
-
bioRxiv - Cancer Biology 2023Quote: ... CB CD34+ cells or primary AML cells were seeded on top of the HS-5 cells and covered with GMP serum-free Stem Cell Growth Medium (CellGenix GmbH) supplemented with 50ng/ml TPO ...
-
bioRxiv - Immunology 2020Quote: ... For direct LC differentiation CD34+ cells were cultured for 7 days in a 24 well tissue culture plate (5×104 cells per well) in serum free CellGro DC medium (CellGenix, Freiburg, Germany) supplemented with Glutamax ...
-
bioRxiv - Immunology 2020Quote: ... monocytes obtained from leukapheresis product (REC Project no: 2013/624-15) were cultured for 2 days in CellGro DC medium (CellGenix, Freiburg, Germany) supplemented with GM-CSF and Interleukin-4 (IL-4 ...
-
bioRxiv - Immunology 2020Quote: ... NK ratio and recombinant human IL-2 (Proleukin, 200 U/ml; Chiron, Emeryville, CA, USA) in complete CellGenix GMP SCGM Stem Cell Growth Medium (CellGenix GmbH, Freiburg, Germany) on day 0 ...
-
bioRxiv - Immunology 2020Quote: ... at 2:1 feeder cell:NK ratio and recombinant human IL-2 (Proleukin, 200 Chiron, Emeryville, CA, USA) in complete stem cell growth medium (SCGM, CellGenix GmbH, Freiburg, Germany) on day 0 ...